Follow-on Offering
Venture Company Succeeds in Additional Nasdaq Fundraising Immediately After IPO On January 28, 2022, Mainz Biomed N.V., a German molecular genetics diagnostic venture focused on the early detection of cancer, conducted its second public offering. It sold 1.5 million shares at $15 per share, raising $22.5 million (approx. 2.7 billion JPY, converted at 120 JPY/USD). …